Original
La efectividad del tratamiento con omalizumab en la vida real es menor en pacientes con urticaria crónica de más de 18 meses de evolución y tratamiento inmunosupresor previo
The Effectiveness of Omalizumab Treatment in Real-Life is Lower in Patients with Chronic Urticaria Longer than 18 Months’ Evolution and Prior Immunosuppressive Treatment
X. Cubiró
, J. Spertino, E. Rozas-Muñoz, E. Serra-Baldrich, L. Puig
Autor para correspondencia
Departamento de Dermatología, Hospital de la Santa Creu i Sant Pau, Universidad Autónoma de Barcelona, Barcelona, España
Leído
12653
Vecesse ha leído el artículo
2561
Total PDF
10092
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 85 | 39 | 124 |
| 2025 5 | 245 | 38 | 283 |
| 2025 4 | 245 | 22 | 267 |
| 2025 3 | 183 | 27 | 210 |
| 2025 2 | 218 | 36 | 254 |
| 2025 1 | 192 | 33 | 225 |
| 2024 12 | 159 | 38 | 197 |
| 2024 11 | 180 | 66 | 246 |
| 2024 10 | 161 | 39 | 200 |
| 2024 9 | 148 | 38 | 186 |
| 2024 8 | 206 | 74 | 280 |
| 2024 7 | 200 | 45 | 245 |
| 2024 6 | 244 | 56 | 300 |
| 2024 5 | 311 | 71 | 382 |
| 2024 4 | 222 | 50 | 272 |
| 2024 3 | 186 | 40 | 226 |
| 2024 2 | 189 | 59 | 248 |
| 2024 1 | 265 | 49 | 314 |
| 2023 12 | 214 | 29 | 243 |
| 2023 11 | 191 | 51 | 242 |
| 2023 10 | 176 | 49 | 225 |
| 2023 9 | 202 | 37 | 239 |
| 2023 8 | 133 | 20 | 153 |
| 2023 7 | 174 | 44 | 218 |
| 2023 6 | 118 | 35 | 153 |
| 2023 5 | 196 | 35 | 231 |
| 2023 4 | 124 | 21 | 145 |
| 2023 3 | 155 | 17 | 172 |
| 2023 2 | 137 | 32 | 169 |
| 2022 1 | 104 | 36 | 140 |
| 2022 12 | 112 | 48 | 160 |
| 2022 11 | 145 | 37 | 182 |
| 2022 10 | 163 | 41 | 204 |
| 2022 9 | 99 | 40 | 139 |
| 2022 8 | 102 | 53 | 155 |
| 2022 7 | 112 | 42 | 154 |
| 2022 6 | 141 | 46 | 187 |
| 2022 5 | 161 | 35 | 196 |
| 2022 4 | 129 | 40 | 169 |
| 2022 3 | 175 | 60 | 235 |
| 2022 2 | 165 | 23 | 188 |
| 2021 1 | 172 | 49 | 221 |
| 2021 12 | 113 | 36 | 149 |
| 2021 11 | 115 | 42 | 157 |
| 2021 10 | 124 | 61 | 185 |
| 2021 9 | 78 | 54 | 132 |
| 2021 8 | 97 | 35 | 132 |
| 2021 7 | 94 | 34 | 128 |
| 2021 6 | 105 | 43 | 148 |
| 2021 5 | 145 | 54 | 199 |
| 2021 4 | 207 | 51 | 258 |
| 2021 3 | 172 | 46 | 218 |
| 2021 2 | 90 | 35 | 125 |
| 2020 1 | 84 | 27 | 111 |
| 2020 12 | 88 | 26 | 114 |
| 2020 11 | 86 | 26 | 112 |
| 2020 10 | 90 | 21 | 111 |
| 2020 9 | 102 | 22 | 124 |
| 2020 8 | 101 | 14 | 115 |
| 2020 7 | 120 | 14 | 134 |
| 2020 6 | 116 | 35 | 151 |
| 2020 5 | 154 | 29 | 183 |
| 2020 4 | 148 | 17 | 165 |
| 2020 3 | 216 | 21 | 237 |
| 2020 2 | 9 | 2 | 11 |
| 2020 1 | 1 | 0 | 1 |
| 2019 12 | 2 | 0 | 2 |
| 2019 11 | 2 | 2 | 4 |
| 2019 10 | 11 | 4 | 15 |
| 2019 9 | 4 | 4 | 8 |
| 2019 8 | 3 | 6 | 9 |
| 2019 7 | 5 | 4 | 9 |
| 2019 6 | 10 | 8 | 18 |
| 2019 5 | 141 | 30 | 171 |
| 2019 4 | 7 | 4 | 11 |
| 2019 3 | 1 | 0 | 1 |
| 2019 2 | 2 | 4 | 6 |
| 2019 1 | 6 | 4 | 10 |
| 2018 12 | 1 | 2 | 3 |
| 2018 11 | 2 | 4 | 6 |
| 2018 10 | 1 | 0 | 1 |
Mostrar todo
